1. A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics. Issue 1 (22nd August 2022) Authors: Lehtisalo, Minna; Taskinen, Suvi; Tarkiainen, E. Katriina; Neuvonen, Mikko; Viinamäki, Jenni; Paile‐Hyvärinen, Maria; Lilius, Tuomas O.; Tapaninen, Tuija; Backman, Janne T.; Tornio, Aleksi; Niemi, Mikko Journal: British journal of clinical pharmacology Issue: Volume 89:Issue 1(2023) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A time‐to‐event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A. (24th September 2013) Authors: Frobel, Anne‐Kristina; Karlsson, Mats O.; Backman, Janne T.; Hoppu, Kalle; Qvist, Erik; Seikku, Paula; Jalanko, Hannu; Holmberg, Christer; Keizer, Ron J.; Fanta, Samuel; Jönsson, Siv Journal: British journal of clinical pharmacology Issue: Volume 76:Number 4(2013:Oct.) Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A time‐to‐event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A. (24th September 2013) Authors: Frobel, Anne‐Kristina; Karlsson, Mats O.; Backman, Janne T.; Hoppu, Kalle; Qvist, Erik; Seikku, Paula; Jalanko, Hannu; Holmberg, Christer; Keizer, Ron J.; Fanta, Samuel; Jönsson, Siv Journal: British journal of clinical pharmacology Issue: Volume 76:Number 4(2013:Oct.) Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A3 - A High-throughput double cocktail approach for evaluating time-dependent inhibition of nine major human cytochrome P450 enzymes. (2020) Authors: Kahma, Helinä; Aurinsalo, Laura; Neuvonen, Mikko; Viinamäki, Jenni; Launiainen, Terhi; Filppula, Anne M.; Tornio, Aleksi; Backman, Janne T. Journal: Drug metabolism and pharmacokinetics Issue: Volume 35(2020)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Studies on Drug–Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation. Issue 6 (20th April 2019) Authors: Tornio, Aleksi; Filppula, Anne M.; Niemi, Mikko; Backman, Janne T. Journal: Clinical pharmacology & therapeutics Issue: Volume 105:Issue 6(2019) Page Start: 1345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8‐Mediated Metabolism of Montelukast in Humans. Issue 3 (23rd December 2017) Authors: Itkonen, Matti K.; Tornio, Aleksi; Filppula, Anne M.; Neuvonen, Mikko; Neuvonen, Pertti J.; Niemi, Mikko; Backman, Janne T. Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 3(2018) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel. Issue 1 (9th August 2018) Authors: Itkonen, Matti K.; Tornio, Aleksi; Lapatto‐Reiniluoto, Outi; Neuvonen, Mikko; Neuvonen, Pertti J.; Niemi, Mikko; Backman, Janne T. Journal: Clinical pharmacology & therapeutics Issue: Volume 105:Issue 1(2019) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics. Issue 1 (6th November 2017) Authors: Hirvensalo, Päivi; Tornio, Aleksi; Neuvonen, Mikko; Tapaninen, Tuija; Paile‐Hyvärinen, Maria; Kärjä, Vesa; Männistö, Ville T.; Pihlajamäki, Jussi; Backman, Janne T.; Niemi, Mikko Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 1(2018) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or Prasugrel. Issue 2 (20th August 2018) Authors: Holmberg, Mikko T.; Tornio, Aleksi; Paile‐Hyvärinen, Maria; Tarkiainen, E. Katriina; Neuvonen, Mikko; Neuvonen, Pertti J.; Backman, Janne T.; Niemi, Mikko Journal: Clinical pharmacology & therapeutics Issue: Volume 105:Issue 2(2019) Page Start: 448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Drug‐Related Inadvertent Deaths in a University Hospital – A Declining Trend. Issue 6 (21st July 2015) Authors: Lapatto‐Reiniluoto, Outi; Patinen, Laura; Niemi, Mikko; Backman, Janne T.; Neuvonen, Pertti J. Journal: Basic & clinical pharmacology & toxicology Issue: Volume 117:Issue 6(2015) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗